Future Oncology, Volume 16, Issue 2 (2020)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Future Oncology, Volume 16, Issue 2 (2020)

See all volumes and issues
Vol 20, 2024 Vol 19, 2023 Vol 18, 2022 Vol 17, 2021 Volume 16, 2020 Vol 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Vol 11, 2015 Vol 10, 2014 Vol 9, 2013 Vol 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs Download issue

Editorial

Editorial
Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients
Marco Puzzoni, Pina Ziranu, Laura Demurtas, Eleonora Lai, Stefano Mariani, Nicole Liscia, Paolo Soro, Andrea Pretta, Valentino Impera, Silvia Camera, Francesca Musio, Mara Persano, Clelia Donisi, Simona Tolu, Francesca Balconi & Mario Scartozzi
Pages: 4337-4339
Published online: 03 Dec 2019
First Page PreviewforWhy precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients | Full Text | References | PDF (1.2 MB) | EPUB
  • 1356 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Short Communication

Brief Report
First-line immune checkpoint inhibitor use in cisplatin-eligible patients with advanced urothelial carcinoma: a secular trend analysis
Ravi B Parikh, Emily K Feld, Matthew D Galsky, Blythe JS Adamson, Aaron B Cohen, Shrujal S Baxi, Shimon Ben Boursi, John P Christodouleas, David J Vaughn, Neal J Meropol & Ronac Mamtani
Pages: 4341-4345
Published online: 16 Dec 2019
AbstractforFirst-line immune checkpoint inhibitor use in cisplatin-eligible patients with advanced urothelial carcinoma: a secular trend analysis | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 280 Views
  • 0 CrossRef citations
  • 0Altmetric

Clinical Trial Protocol

Review Article
Isatuximab plus carfilzomib/dexamethasone versus carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma: IKEMA Phase III study design
Philippe Moreau, Meletios A Dimopoulos, Kwee Yong, Joseph Mikhael, Marie-Laure Risse, Gaëlle Asset & Thomas Martin
Pages: 4347-4358
Published online: 13 Dec 2019
AbstractforIsatuximab plus carfilzomib/dexamethasone versus carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma: IKEMA Phase III study design | Full Text | References | PDF (2.1 MB) | EPUB
  • 14813 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Review Article
ENERGIZE: a Phase III study of neoadjuvant chemotherapy alone or with nivolumab with/without linrodostat mesylate for muscle-invasive bladder cancer
Guru Sonpavde, Andrea Necchi, Shilpa Gupta, Gary D Steinberg, Juergen E Gschwend, Michiel Simon Van Der Heijden, Nathalie Garzon, Mohammed Ibrahim, Bradley Raybold, Danny Liaw, Mark Rutstein & Matt D Galsky
Pages: 4359-4368
Published online: 11 Dec 2019
AbstractforENERGIZE: a Phase III study of neoadjuvant chemotherapy alone or with nivolumab with/without linrodostat mesylate for muscle-invasive bladder cancer | Full Text | References | PDF (2.5 MB) | EPUB
  • 10039 Views
  • 0 CrossRef citations
  • 0Altmetric

Research Article

Article
A prognostic nomogram in patients with distant metastasis of pancreatic neuroendocrine tumors: a population-based study
Jin-Song Cai, Hai-Yan Chen, Yuan-Fei Lu & Ri-Sheng Yu
Pages: 4369-4379
Published online: 05 Dec 2019
AbstractforA prognostic nomogram in patients with distant metastasis of pancreatic neuroendocrine tumors: a population-based study | Full Text | References | PDF (1.5 MB) | EPUB
  • 222 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Gene set based systematic analysis of prostate cancer and its subtypes
Senlin Ye, Haohui Wang, Kancheng He, Hongwei Shen, Mou Peng, Yeqi Nian, Rongrong Cui & Lu Yi
Pages: 4381-4393
Published online: 09 Dec 2019
AbstractforGene set based systematic analysis of prostate cancer and its subtypes | Full Text | References | PDF (2.6 MB) | EPUB
  • 166 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review Article
The role of bosutinib in the treatment of chronic myeloid leukemia
Carlo Gambacorti-Passerini, Philipp le Coutre & Rocco Piazza
Pages: 4395-4408
Published online: 13 Dec 2019
AbstractforThe role of bosutinib in the treatment of chronic myeloid leukemia | Full Text | References | PDF (1.4 MB) | EPUB
  • 7028 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Systematic Review

Review Article
Third- and later-line treatment in advanced or metastatic gastric cancer: a systematic review and meta-analysis
Alessandro Rizzo, Veronica Mollica, Angela Dalia Ricci, Ilaria Maggio, Maria Massucci, Fabiola Lorena Rojas Limpe, Francesca Di Fabio & Andrea Ardizzoni
Pages: 4409-4418
Published online: 03 Dec 2019
AbstractforThird- and later-line treatment in advanced or metastatic gastric cancer: a systematic review and meta-analysis | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 318 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

The TALAPRO-3 study design: a plain language summary
Neeraj Agarwal et al.
Plain Language Summary of Publication | Published online: 24 Jul 2024
Open Access
STELLAR-303: randomized phase III study of zanzalintinib + atezolizumab in previously treated metastatic colorectal cancer
Anwaar Saeed et al.
Method | Published online: 23 Jul 2024
Gastric cancer in pregnancy: a review
Hongming Liu et al.
Review Article | Published online: 23 Jul 2024
A novel prognostic index for extranodal natural killer/T-cell lymphoma in the era of pegaspargase/L-asparaginase
Ziyuan Shen et al.
Article | Published online: 23 Jul 2024
View all latest articles